Efficacy and safety of once-weekly semaglutide 1.0mg vs once-daily liraglutide 1.2mg as add-on to 1-3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)
Produkt jest kwalifikowany jako odczynnik chemiczny / materia odniesienia dopuszczony do obrotu na terenie UE, mona go uywa wycznie do bada naukowych
Chronic conditions: Kidney or liver disease and blood disorders like polycythemia vera may need special monitoring Medication interactions: Some drugs can affect how your body responds to B12 therapy
Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes
It also improves tendon, ligament, and bone healing, accurately implementing its own angiogenic effect in the healing
Segnalazione delle reazioni avverse sospette La segnalazione delle reazioni avverse sospette che si verificano dopo lautorizzazione del medicinale importante, in quanto permette un monitoraggio continuo del rapporto beneficio/rischio del medicinale